WATSON 3700 (Ropinirole Hydrochloride Extended-Release 6 mg)
Pill with imprint WATSON 3700 is White, Elliptical / Oval and has been identified as Ropinirole Hydrochloride Extended-Release 6 mg. It is supplied by Watson Laboratories, Inc..
Ropinirole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 6 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WATSON 3700
Ropinirole Hydrochloride Extended-Release
- Imprint
- WATSON 3700
- Strength
- 6 mg
- Color
- White
- Size
- 13.00 mm
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Laboratories, Inc.
- National Drug Code (NDC)
- 00591-3700
- Inactive Ingredients
-
hypromelloses,
mannitol,
glyceryl dibehenate,
lactose monohydrate,
hydrogenated castor oil,
povidone,
sodium lauryl sulfate,
magnesium silicate,
magnesium stearate,
silicon dioxide,
triethyl citrate,
titanium dioxide,
polydextrose,
triacetin,
polyethylene glycol 8000,
vinyl acetate
Note: Inactive ingredients may vary.
More about ropinirole
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 289 Reviews
- Drug class: dopaminergic antiparkinsonism agents
- FDA Alerts (1)
Consumer resources
- Patient Information
- Ropinirole (Advanced Reading)
- Ropinirole Extended-Release Tablets
- Ropinirole Tablets
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.